EMUC16: In Focus: Consequences of pelvic radiotherapy
November 26, 2016Read moreUrological cancer experts were warned on the far-reaching consequences of high-dosage radiation therapy with a dedicated session that examined...
0EMUC16 grants awards to promising research
November 26, 2016Read moreFour awardees were honoured for their promising research at the 8th European Multidisciplinary Meeting on Urological Cancers (EMUC16) in...
EMUC16: Kidney cancer: From diagnosis to progression
November 26, 2016Read moreImproving diagnosis and mapping out optimal treatment strategies for kidney cancer patients topped the second-day agenda of the 8th...
EMUC16: Imaging-guided approaches for PCa recurrences
November 25, 2016Read moreCurrent and prospective treatment strategies that employ image-guided approaches for prostate cancer recurrences were examined with experts exploring options...
EMUC16: Combination therapies in prostate cancer
November 25, 2016Read moreSystemic treatments and optimizing various forms of therapies in high-risk and metastatic forms of prostate cancer were examined at...
EMUC16: Trends in genitourinary pathology and impact on clinical practice
November 24, 2016Read moreNew trends and developments in genitourinary pathology and their impact on current clinical practice were examined and discussed by...
EMUC16: Early cancer detection strategies can ease healthcare disparities in Europe
November 9, 2016Read moreBoosting cancer control in Europe may yet find tenable options by using effective early cancer detection strategies and timely...
EMUC16: Indolent cancers: The fine art of sophisticated pathology
October 19, 2016Read moreIdentifying patients with indolent cancers from those with aggressive disease are one of the many challenges faced by many...
EMUC16: Managing recurrent PCa: Has focal therapies come of age?
September 15, 2016Read moreManaging recurrent prostate cancer (PCa) remains a challenge to cancer experts, but with the wider use of image-guided techniques...
